Literature DB >> 10958655

Characterization of a monoclonal antibody panel shows that the myotonic dystrophy protein kinase, DMPK, is expressed almost exclusively in muscle and heart.

L T Lam1, Y C Pham, T M Nguyen, G E Morris.   

Abstract

Myotonic dystrophy (DM) is a multisystemic disorder caused by an inherited CTG repeat expansion which affects three genes encoding the DM protein kinase (DMPK), a homeobox protein Six5 and a protein containing WD repeats. Using a panel of 16 monoclonal antibodies against several different DMPK epitopes we detected DMPK, as a single protein of approximately 80 kDa, only in skeletal muscle, cardiac muscle and, to a lesser extent, smooth muscle. Many earlier reports of DMPK with different sizes and tissue distributions appear to be due to antibody cross-reactions with more abundant proteins. One such antibody, MANDM1, was used to isolate two related protein kinases, MRCK alpha and beta, from a human brain cDNA library and the shared epitope was located at the catalytic site of DMPK using a phage-displayed random peptide library. The peptide library also identified an epitope shared between DMPK and a 55 kDa muscle-specific protein. The results suggest that effects of the repeat expansion on the DMPK gene may be responsible for muscle and heart features of DM, whereas clinical changes in other tissues may be due to effects on the other two genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958655     DOI: 10.1093/hmg/9.14.2167

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  14 in total

1.  Divergent mitochondrial and endoplasmic reticulum association of DMPK splice isoforms depends on unique sequence arrangements in tail anchors.

Authors:  René E M A van Herpen; Ralph J A Oude Ophuis; Mietske Wijers; Miranda B Bennink; Fons A J van de Loo; Jack Fransen; Bé Wieringa; Derick G Wansink
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

2.  MBNL1 overexpression is not sufficient to rescue the phenotypes in a mouse model of RNA toxicity.

Authors:  Ramesh S Yadava; Yun K Kim; Mahua Mandal; Karunasai Mahadevan; Jordan T Gladman; Qing Yu; Mani S Mahadevan
Journal:  Hum Mol Genet       Date:  2019-07-15       Impact factor: 6.150

3.  Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.

Authors:  Denis Furling; Le Thanh Lam; Onnik Agbulut; Gillian S Butler-Browne; Glenn E Morris
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 4.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

5.  14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking.

Authors:  Mercedes Pozuelo Rubio; Kathryn M Geraghty; Barry H C Wong; Nicola T Wood; David G Campbell; Nick Morrice; Carol Mackintosh
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

6.  Mast cells regulate CD4+ T-cell differentiation in the absence of antigen presentation.

Authors:  Hector Rodriguez Cetina Biefer; Timm Heinbokel; Hirofumi Uehara; Virginia Camacho; Koichiro Minami; Yeqi Nian; Suresh Koduru; Rachid El Fatimy; Ionita Ghiran; Alexander J Trachtenberg; Miguel A de la Fuente; Haruhito Azuma; Omid Akbari; Stefan G Tullius; Anju Vasudevan; Abdallah Elkhal
Journal:  J Allergy Clin Immunol       Date:  2018-02-20       Impact factor: 10.793

7.  Co-crystal structures of inhibitors with MRCKβ, a key regulator of tumor cell invasion.

Authors:  Timo Heikkila; Edward Wheatley; Diane Crighton; Ewald Schroder; Alexandra Boakes; Sarah J Kaye; Mokdad Mezna; Leon Pang; Mathew Rushbrooke; Andrew Turnbull; Michael F Olson
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

8.  Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action.

Authors:  Esther Llagostera; Daniele Catalucci; Luc Marti; Marc Liesa; Marta Camps; Theodore P Ciaraldi; Richard Kondo; Sita Reddy; Wolfgang H Dillmann; Manuel Palacin; Antonio Zorzano; Pilar Ruiz-Lozano; Ramon Gomis; Perla Kaliman
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

Review 9.  The actin-myosin regulatory MRCK kinases: regulation, biological functions and associations with human cancer.

Authors:  Mathieu Unbekandt; Michael F Olson
Journal:  J Mol Med (Berl)       Date:  2014-02-20       Impact factor: 4.599

10.  A novel small-molecule MRCK inhibitor blocks cancer cell invasion.

Authors:  Mathieu Unbekandt; Daniel R Croft; Diane Crighton; Mokdad Mezna; Duncan McArthur; Patricia McConnell; Alexander W Schüttelkopf; Simone Belshaw; Andrew Pannifer; Mairi Sime; Justin Bower; Martin Drysdale; Michael F Olson
Journal:  Cell Commun Signal       Date:  2014-10-05       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.